Third Arc Bio headquarters details
- City
- Philadelphia
- State / region
- Pennsylvania
- ZIP / postal code
- 19132
- Country
- United States
- Founded
- 2022
- Website
- thirdarcbio.com
Location map
Open in Google MapsAll Third Arc Bio office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Philadelphia HQ | Pennsylvania | United States | Headquarters |
Showing the headquarters of 2 recorded locations. See every location in GraphIQ →
About Third Arc Bio
Third Arc Bio is headquartered in Philadelphia, Pennsylvania, United States. Founded in 2022, the company has 2 recorded locations and employs approximately 36 people worldwide.
Where is Third Arc Bio's main office?
Third Arc Bio's main headquarters office is located at Philadelphia, Pennsylvania 19132, United States. This is the company's primary corporate address.
Third Arc Bio regional offices
Beyond its headquarters in Philadelphia, Third Arc Bio has recorded locations in United States.
What does Third Arc Bio do?
Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics - a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.
Frequently asked questions
Where is Third Arc Bio headquarters?
Third Arc Bio's headquarters is located at Philadelphia, Pennsylvania 19132, United States.
How many offices does Third Arc Bio have?
GraphIQ records 2 locations for Third Arc Bio, as of October 2026.
When was Third Arc Bio founded?
Third Arc Bio was founded in 2022 and employs approximately 36 people.
How many employees does Third Arc Bio have?
Third Arc Bio has approximately 36 employees (GraphIQ estimate, 2026).